| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/02/2004 | US20040171566 in a formulation suitable for intranasal, intrapulmonary or intratracheal administration; treating inflammatory diseases, particularly rheumatoid arthritis and asthma |
| 09/02/2004 | US20040171565 vaccines that express derivatives of ADP-ribosyltransferase toxins that display significantly reduced, or are deficient in, intrinsic ADP-ribosyltransferase activity (i.e. herein referred to as mARTs) and yet retain adjuvanticity |
| 09/02/2004 | US20040171564 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171546 Regulation of lung tissue by hedgehog-like polypeptides and formulations and uses related thereto |
| 09/02/2004 | US20040171539 Regulation of human protein kinase-like protein |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171537 Adapter gene |
| 09/02/2004 | US20040171535 Heparanase II, a novel human heparanase paralog |
| 09/02/2004 | US20040171534 chimeric analogs include a hydrophobic moiety (tail), and can be prepared, either by anchoring one or several hydrophobic tails to the GRF, or by substituting one or several amino-acids by a pseudomicellar residue in the chemical synthesis of GRF |
| 09/02/2004 | US20040171517 Compounds and methods for modulating bacterial functions |
| 09/02/2004 | US20040171160 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
| 09/02/2004 | US20040171159 Cell-specific adenovirus vector comprising EBV-specific promoter |
| 09/02/2004 | US20040171158 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 09/02/2004 | US20040171157 Recombinational cloning using nucleic acids having recombination sites |
| 09/02/2004 | US20040171156 for moving or exchanging segments of DNA molecules using proteins to provide chimeric DNA molecules in vitro and in vivo |
| 09/02/2004 | US20040171155 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 09/02/2004 | US20040171154 in such a way that no heterologous sequence is retained after the mutagenesis is complete; employ integrative recombinant oligonucleotides (IROs); kits; genetic engineering |
| 09/02/2004 | US20040171149 Oligonucleotides for controlling growth factor expression and treatment of cell proliferative and skin disorders; antisense agents |
| 09/02/2004 | US20040171147 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 09/02/2004 | US20040171132 Comprises nucleotide sequences coding herpes virus glycoprotein for developing vaccine which prevents respiratory system disorders in poulty; veterinary medicine; genetic vaccines |
| 09/02/2004 | US20040171130 Comprises polypeptide associated with pentose phosphate pathway for use in preparation of amino acids for use in cosmetics, foods and pharmeceuticals |
| 09/02/2004 | US20040171125 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171122 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171119 Reductase gene and use of the same |
| 09/02/2004 | US20040171118 Using RNA interference to control hypermethylation of tumor suppressor genes; antitumor agents |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171116 Recombinant protein variants |
| 09/02/2004 | US20040171115 Comprises hematopoietic protein modulator for use in proliferation and diffefrentiation of bone marrow cells |
| 09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171109 Comprises nucleotide sequences coding interleukin receptor protein for use in the diagnosis, prevention and treatment of bone disorders; gene therapy |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171107 Modified flourescent proteins |
| 09/02/2004 | US20040171106 Process for producing dipeptides |
| 09/02/2004 | US20040171104 may be used in food related applications to improve flavor, such as baking; genetic engineering |
| 09/02/2004 | US20040171065 Method for expression of proteins on spore surface |
| 09/02/2004 | US20040171060 Replicating and amplifying target nucleic acid sequence using polymerase, helicase and holliday structures; low temperature DNA amplification |
| 09/02/2004 | US20040171059 Comprises nucleotide sequences coding enzymatic polypeptide associated with programed cell death for identifying modulators for treatment of inflammatory, neurodegenerative and cell proliferative disorders |
| 09/02/2004 | US20040171058 Preparing chimeric ribozyme for use in treatment of viral diseases; viricides |
| 09/02/2004 | US20040171053 Solid support comprising microparticles with known addresses for use in analysis of gene expression, drug discovery and disease diagnostics |
| 09/02/2004 | US20040171052 Using intracellular expression of cytokines to prognosis outcomes of viral, cell proliferative and inflammatory diseases and/or drug therapies |
| 09/02/2004 | US20040171044 Peptide nucleic acid for transfer of proteins, drug agents or nucleotide sequences to cells; intracellular compound deposition |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171039 Loop probe hybridization assay for polynucleotide analysis |
| 09/02/2004 | US20040171038 IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 09/02/2004 | US20040171037 Using genic copy number of oncogenes to diagnose, prevent and treat tumor disorders; antitumor agents |
| 09/02/2004 | US20040171033 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171031 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171030 Oligonucleotide sequences capable of binding RNA-induced silencing complexes for use in treatment and prevention of metabolic and cell proliferative disorders |
| 09/02/2004 | US20040171019 Comprises nucleotide sequences coding isomerase which catalyzes rotation about proline residues for identifying modulators and designing treatments for cell proliferative disorders |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171007 Using oligonuclleotide and DNA amplification to identify mycobacterium in biological samples; clinical diagnostics |
| 09/02/2004 | US20040171006 Comprises nucleotide sequences coding enzymatic polypeptide treatment and prevention of cancers, nervous system, urogenital, hematological and gastro-intestinal disorders |
| 09/02/2004 | US20040171005 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 09/02/2004 | US20040171003 Using oligonucleotide probes to generate gene expression profile of tumor marker proteins for use in diagnosis of cell proliferative disorders |
| 09/02/2004 | US20040171002 Apparatus comprising receptor immobilized flow channel for conducting and monitoring multiple binding reactions associated with parrallel flow of reactants over substrate; microarrays and biosensors |
| 09/02/2004 | US20040171000 Comprises nucleotide sequences coding yeast telomerase subunit (EST-1) for identifying modulators for prevention and tredatment of cell proliferative and aging related disorders |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170997 used in drug screening for preventing or treating diseases associated with abnormalities in intracellular signal transduction; genetic engineering |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170994 DNA sequences for human tumour suppressor genes |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170991 can be employed as a sample preparation procedure performed prior to replication; comprises treating with pohosphate solution/centrifuging; genetic engineering |
| 09/02/2004 | US20040170990 capable of binding to a guanine nucleotide exchange factor for ADP ribosylation factors; for drug screening in vitro/vivo; genetic engineering |
| 09/02/2004 | US20040170989 Cellular gene targets for controlling cell growth |
| 09/02/2004 | US20040170988 Modified solid carrier and DNA detection device |
| 09/02/2004 | US20040170986 Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| 09/02/2004 | US20040170980 Molecules capable of binding to telomere and the like and method with the use of the same |
| 09/02/2004 | US20040170979 Dna encoding l-ribose isomerase and uses thereof |
| 09/02/2004 | US20040170977 kits for diagnosis or prognosis of cancer or cancer-related conditions based upon methylation states; microarrays; genetic engineering |
| 09/02/2004 | US20040170976 for drug screening expression libraries for microbiocides; solid phase synthesis; genetic engineering |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170969 GRF2 binding proteins and applications thereof |
| 09/02/2004 | US20040170968 Artificial long terminal repeat vectors |
| 09/02/2004 | US20040170963 for gene expression inhibition drugs; genetic engineering |
| 09/02/2004 | US20040170962 Single LTR lentivirus vector |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170959 Methods for identifying antiviral oligonucleotides |
| 09/02/2004 | US20040170957 by extracting RNA from plasma and serum, polymerase chain reaction (PCR); for simply and exactly examining the analysis of genotype for four people on one slide |
| 09/02/2004 | US20040170956 Method for identifying targeting domains and methods and compositions comprising the same |
| 09/02/2004 | US20040170955 Human and mouse targeting peptides identified by phage display |
| 09/02/2004 | US20040170952 Reagents and methods for the detection of genes associated with the major histocompatibility complex of domestic fowl, such as chicken |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170647 Recombinant adenovirus vaccines |
| 09/02/2004 | US20040170646 Preferred are EB1 or EB14 cell; canary poxvirus containins a exogenous DNA sequence that encodes a tumor antigen, an antigen derived from a human pathogen, or a fragment thereof; vaccines |
| 09/02/2004 | US20040170643 heat shock protein fused to a single epitope-containing segment comprising two or more identical epitopes and a DNA construct encoding it; reducing levels of a predetermined protein (e.g., hormone(s)) in an animal; vaccines |
| 09/02/2004 | US20040170641 Prevention and treatment of amyloidogenic disease |
| 09/02/2004 | US20040170624 active principle, especially the humanized monoclonal antibody JAQ1, that induces irreversible inactivation or degradation of the collagen receptor on thrombocytes; diagnostic agent for the determination of the expression rate of the collagen receptor GPVI |
| 09/02/2004 | US20040170619 contacting a nucleic acid binding polypeptide, preferably a zinc finger polypeptide, with a nucleic acid sequence in the primary cell to regulate its expression; |
| 09/02/2004 | US20040170616 transferring a gene to preselected vertebrate cells by accelerating microprojectiles carrying polynucleic acid sequences having a regulatory sequence in the 5' to 3' direction and a gene downstream from the sequence at the cells to penetrate them and deposit the polynucleic acid sequences therein. |
| 09/02/2004 | US20040170614 Somatic cell gene targeting vectors and methods of use thereof |